Arturo Molina MD - 16 Jan 2023 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role: Chief Medical Officer
Signature: /s/ Asif Ali, Attorney-in-Fact for Arturo Molina, MD
Issuer symbol: PTGX
Transactions as of: 16 Jan 2023
Net transactions value: $0
Form type: 4
Filing time: 18 Jan 2023, 18:51:01 UTC
Previous filing: 17 Nov 2022
Next filing: 04 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PTGX	Common Stock	Award	$0	+3,125	+15%	$0.000000	24,375	16 Jan 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PTGX	Stock Option (right to buy)	Award	$0	+18,750		$0.000000	18,750	16 Jan 2023	Common Stock	18,750	$12.17	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents grant of restricted stock units payable solely in common stock that will vest in three annual installments on January 15, 2024, 2025 and 2026.
F2	The stock option vests in 48 equal monthly installments following the date of grant.